553 related articles for article (PubMed ID: 26583099)
1. Th17 Cell Plasticity and Functions in Cancer Immunity.
Guéry L; Hugues S
Biomed Res Int; 2015; 2015():314620. PubMed ID: 26583099
[TBL] [Abstract][Full Text] [Related]
2. The paradox of Th17 cell functions in tumor immunity.
Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
[TBL] [Abstract][Full Text] [Related]
3. The role of T helper 17 and regulatory T cells in tumor microenvironment.
Najafi S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):16-24. PubMed ID: 30714422
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer.
Iida T; Iwahashi M; Katsuda M; Ishida K; Nakamori M; Nakamura M; Naka T; Ojima T; Ueda K; Hayata K; Nakamura Y; Yamaue H
Oncol Rep; 2011 May; 25(5):1271-7. PubMed ID: 21369705
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer.
Song Y; Yang JM
Biochem Biophys Res Commun; 2017 Nov; 493(1):1-8. PubMed ID: 28859982
[TBL] [Abstract][Full Text] [Related]
6. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.
Renaude E; Kroemer M; Loyon R; Binda D; Borg C; Guittaut M; Hervouet E; Peixoto P
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121394
[TBL] [Abstract][Full Text] [Related]
7. Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.
Stewart CA; Metheny H; Iida N; Smith L; Hanson M; Steinhagen F; Leighty RM; Roers A; Karp CL; Müller W; Trinchieri G
J Clin Invest; 2013 Nov; 123(11):4859-74. PubMed ID: 24216477
[TBL] [Abstract][Full Text] [Related]
8. [The role of Th17 cells in anti-cancer immunity].
Hus I; Maciag E; Roliński J
Postepy Hig Med Dosw (Online); 2010 May; 64():244-50. PubMed ID: 20498501
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells.
Hemdan NY
Immunol Lett; 2013 Jan; 149(1-2):123-33. PubMed ID: 23159638
[TBL] [Abstract][Full Text] [Related]
10. IL-10: master switch from tumor-promoting inflammation to antitumor immunity.
Oft M
Cancer Immunol Res; 2014 Mar; 2(3):194-9. PubMed ID: 24778315
[TBL] [Abstract][Full Text] [Related]
11. Functional plasticity of Th17 cells: implications in gastrointestinal tract function.
Garrido-Mesa N; Algieri F; Rodríguez Nogales A; Gálvez J
Int Rev Immunol; 2013; 32(5-6):493-510. PubMed ID: 24040751
[TBL] [Abstract][Full Text] [Related]
12. [Do Th17 cells play an important role in the pathogenesis and prognosis of ovarian cancer?].
Winkler I; Gogacz M; Rechberger T
Ginekol Pol; 2012 Apr; 83(4):295-300. PubMed ID: 22712263
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis.
Qian X; Chen H; Wu X; Hu L; Huang Q; Jin Y
Cytokine; 2017 Jan; 89():34-44. PubMed ID: 26883678
[TBL] [Abstract][Full Text] [Related]
14. Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity.
Ankathatti Munegowda M; Deng Y; Mulligan SJ; Xiang J
Cancer Immunol Immunother; 2011 Oct; 60(10):1473-84. PubMed ID: 21660450
[TBL] [Abstract][Full Text] [Related]
15. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
Astry B; Venkatesha SH; Moudgil KD
Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-regulated Th17 plasticity in human health and diseases.
Cerboni S; Gehrmann U; Preite S; Mitra S
Immunology; 2021 May; 163(1):3-18. PubMed ID: 33064842
[TBL] [Abstract][Full Text] [Related]
18. Targeting the interleukin-17 immune axis for cancer immunotherapy.
Vitiello GA; Miller G
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727783
[TBL] [Abstract][Full Text] [Related]
19. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
Du R; Zhao H; Yan F; Li H
J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
[TBL] [Abstract][Full Text] [Related]
20. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer.
Chang SH
Arch Pharm Res; 2019 Jul; 42(7):549-559. PubMed ID: 30941641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
